Caribou Biosciences, Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$-2
Book Value Per Share
$1
Free Cash Flow Per Share
$-1
Cash Per Share
$0
Revenue Per Share
$0
OCF Per Share
$-1
Return on Equity
-79.0%
Return on Assets
-60.6%
Return on Invested Capital
-62.5%
Current Ratio
5.71
Quick Ratio
5.71
Asset Turnover
0.05
Days Sales Outstanding
2.26
R&D / Revenue
980.7%
SBC / Revenue
113.6%
Capex / Revenue
12.2%
Working Capital
$120M
Net Current Asset Value
$92M
Invested Capital
$122M
OCF / Net Income
0.75
FCF / Net Income
0.76
Accruals Ratio (Sloan)
-21.2%
Net Debt
$-12M
Net Debt / EBITDA
0.09
Interest Coverage
—
Cash Coverage
—
Capex Coverage
-81.67
Tangible Common Equity
$122M
TCE / Total Assets
69.7%
NOPAT
$-117M
Cash ROIC
-59.9%
WC / Revenue
1073.7%
Capex / D&A
0.37
Reinvestment Rate
1.5%
Asset Growth vs Revenue Growth
-55.7%
Revenue 5Y CAGR
-2.0%
Book Value 5Y CAGR
102.3%
Stock Price (FY-end)
$2
Market Cap
$148M
P/S Ratio
13.31
P/B Ratio
1.22
P/TB Ratio
1.22
Enterprise Value
$136M
EV / Sales
12.20
FCF Yield
-75.7%
Shareholder Yield
-8.5%
R&D Yield
73.7%
Capex Yield
0.9%
Shares Variation (YoY)
3.4%
Beta (5Y)
1.85
Cost of Equity
13.8%
52W High
$3
52W Low
$1
Trailing Return 1Y
-4.8%
F-Score (Piotroski)
2.00
Z-Score (Altman)
-5.00
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.